Purkiss Capital Advisors LLC Prothena Corp Public LTD CO Transaction History
Purkiss Capital Advisors LLC
- $132 Billion
- Q1 2025
A detailed history of Purkiss Capital Advisors LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Purkiss Capital Advisors LLC holds 21,629 shares of PRTA stock, worth $157,675. This represents 0.2% of its overall portfolio holdings.
Number of Shares
21,629
Previous 10,729
101.59%
Holding current value
$157,675
Previous $149 Million
80.12%
% of portfolio
0.2%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding PRTA
# of Institutions
187Shares Held
43.7MCall Options Held
251KPut Options Held
79.2K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$84.4 Million11.27% of portfolio
-
Wellington Management Group LLP Boston, MA5.2MShares$37.9 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$28.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.46MShares$25.2 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.2MShares$16 Million0.41% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $342M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...